Intrinsic value of Takeda Pharmaceutical Company Limited (TAK)
Live fair value data for Takeda Pharmaceutical Company Limited (TAK) is currently unavailable. Please check again shortly.
Current Price: $114.00
Valuation: Undervalued
Confidence: 8.0/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Takeda Pharmaceutical Company Limited (TAK) undervalued or overvalued?
Based on the current model output, Takeda Pharmaceutical Company Limited appears to be undervalued with a upside of 47.00%.
Fair value vs market price — Takeda Pharmaceutical Company Limited (TAK)
Unlock premium access to view the live fair value comparison against current market price for TAK.
Frequently Asked Questions - TAK
How is TAK intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for TAK.
Is TAK undervalued or overvalued right now?
TAK is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for TAK: open their intrinsic value pages.